Department of Surgery, Division of Cardiothoracic Surgery, The Ohio State University, Columbus, Ohio 43210, USA.
J Surg Res. 2010 Sep;163(1):162-8. doi: 10.1016/j.jss.2010.04.021. Epub 2010 May 11.
M290SAP, a murine CD103 antibody conjugated with the immunotoxin saporin, has been found to induce the indefinite acceptance of transplanted pancreatic islets in mice. We sought to understand the underlying mechanism of this alloacceptance, particularly with respect to the CD4 CD25 T regulatory phenotype.
In this study, we established the kinetics of M290SAP and evaluated the requirement of alloantigen for the induction and maintenance of CD4 CD25 T regulatory cells (Tregs). Naive C57BL/6 mice were treated with several doses of M290SAP with and without donor-specific blood or splenocytes. Blood and spleens were collected at specific time points and underwent FACS analysis.
M290SAP significantly depleted CD103 cells and induced the up-regulation of CD4 CD25 T regulatory population in spleen cell preparations. The combination of alloantigen in the form of donor-specific blood or splenocytes, with M290SAP, further induced the up-regulation of CD4 CD25 Tregs in the spleen compared with either M290SAP alone or alloantigen alone. The generation of CD4 CD25 cells and the depletion of CD103 cells reached a maximum at 7 d and by 3 wk CD103 and CD4 CD25 T regulatory cell populations returned to baseline. When multiple antigenic challenges were administered, the splenic CD4 CD25 cell population was again up-regulated and persisted for 3 wk.
Our data confirm that M290SAP induces the generation of the CD4 CD25 T regulatory phenotype in spleens of naïve mice. Alloantigen further enhances and rejuvenates the CD4 CD25 cell population in mice treated with M290SAP.
M290SAP 是一种与蓖麻毒素结合的鼠 CD103 抗体,已被发现可诱导小鼠对移植胰岛的无限接受。我们试图了解这种同种异体接受的潜在机制,特别是针对 CD4 CD25 T 调节表型。
在这项研究中,我们建立了 M290SAP 的动力学,并评估了同种异体抗原对诱导和维持 CD4 CD25 T 调节细胞(Tregs)的要求。用几种剂量的 M290SAP 处理未成熟的 C57BL/6 小鼠,同时给予或不给予供体特异性血液或脾细胞。在特定时间点收集血液和脾脏,并进行 FACS 分析。
M290SAP 可显著耗竭 CD103 细胞,并诱导脾细胞制剂中 CD4 CD25 T 调节群体的上调。与 M290SAP 单独或同种异体抗原单独处理相比,以供体特异性血液或脾细胞形式存在的同种异体抗原与 M290SAP 联合使用,进一步诱导脾中 CD4 CD25 Tregs 的上调。CD4 CD25 细胞的产生和 CD103 细胞的耗竭在第 7 天达到最大值,并且在第 3 周时 CD103 和 CD4 CD25 T 调节细胞群恢复到基线。当给予多次抗原性挑战时,脾 CD4 CD25 细胞群再次上调并持续 3 周。
我们的数据证实 M290SAP 可诱导幼稚小鼠脾脏中产生 CD4 CD25 T 调节表型。同种异体抗原进一步增强和恢复 M290SAP 处理小鼠中的 CD4 CD25 细胞群。